Literature DB >> 27344218

Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth.

Cristina T Navarrete1, Lisa A Wrage2, Waldemar A Carlo3, Michele C Walsh4, Wade Rich5, Marie G Gantz2, Abhik Das6, Kurt Schibler7, Nancy S Newman5, Anthony J Piazza8, Brenda B Poindexter9, Seetha Shankaran10, Pablo J Sánchez11, Brenda H Morris12, Ivan D Frantz13, Krisa P Van Meurs14, C Michael Cotten15, Richard A Ehrenkranz16, Edward F Bell17, Kristi L Watterberg18, Rosemary D Higgins19, Shahnaz Duara20.   

Abstract

OBJECTIVE: To test whether infants randomized to a lower oxygen saturation (peripheral capillary oxygen saturation [SpO2]) target range while on supplemental oxygen from birth will have better growth velocity from birth to 36 weeks postmenstrual age (PMA) and less growth failure at 36 weeks PMA and 18-22 months corrected age. STUDY
DESIGN: We evaluated a subgroup of 810 preterm infants from the Surfactant, Positive Pressure, and Oxygenation Randomized Trial, randomized at birth to lower (85%-89%, n = 402, PMA 26 ± 1 weeks, birth weight 839 ± 186 g) or higher (91%-95%, n = 408, PMA 26 ± 1 weeks, birth weight 840 ± 191 g) SpO2 target ranges. Anthropometric measures were obtained at birth, postnatal days 7, 14, 21, and 28; then at 32 and 36 weeks PMA; and 18-22 months corrected age. Growth velocities were estimated with the exponential method and analyzed with linear mixed models. Poor growth outcome, defined as weight <10th percentile at 36 weeks PMA and 18-22 months corrected age, was compared across the 2 treatment groups by the use of robust Poisson regression.
RESULTS: Growth outcomes including growth at 36 weeks PMA and 18-22 months corrected age, as well as growth velocity were similar in the lower and higher SpO2 target groups.
CONCLUSION: Targeting different oxygen saturation ranges between 85% and 95% from birth did not impact growth velocity or reduce growth failure in preterm infants.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ELBW growth; oxygen saturation target

Mesh:

Substances:

Year:  2016        PMID: 27344218      PMCID: PMC5327617          DOI: 10.1016/j.jpeds.2016.05.070

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  31 in total

1.  Multicenter crossover study of automated control of inspired oxygen in ventilated preterm infants.

Authors:  Nelson Claure; Eduardo Bancalari; Carmen D'Ugard; Leif Nelin; Melanie Stein; Rangasamy Ramanathan; Richard Hernandez; Steven M Donn; Michael Becker; Thomas Bachman
Journal:  Pediatrics       Date:  2010-12-27       Impact factor: 7.124

2.  Nurse:patient ratio and achievement of oxygen saturation goals in premature infants.

Authors:  David W Sink; Shelly Ann E Hope; James I Hagadorn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2010-10-30       Impact factor: 5.747

3.  Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial.

Authors:  Reese H Clark; Donald H Chace; Alan R Spitzer
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

4.  Low oxygen saturation target range is associated with increased incidence of intermittent hypoxemia.

Authors:  Juliann M Di Fiore; Michele Walsh; Lisa Wrage; Wade Rich; Neil Finer; Waldemar A Carlo; Richard J Martin
Journal:  J Pediatr       Date:  2012-06-26       Impact factor: 4.406

5.  Longitudinal growth of hospitalized very low birth weight infants.

Authors:  R A Ehrenkranz; N Younes; J A Lemons; A A Fanaroff; E F Donovan; L L Wright; V Katsikiotis; J E Tyson; W Oh; S Shankaran; C R Bauer; S B Korones; B J Stoll; D K Stevenson; L A Papile
Journal:  Pediatrics       Date:  1999-08       Impact factor: 7.124

6.  Early nutrition mediates the influence of severity of illness on extremely LBW infants.

Authors:  Richard A Ehrenkranz; Abhik Das; Lisa A Wrage; Brenda B Poindexter; Rosemary D Higgins; Barbara J Stoll; William Oh
Journal:  Pediatr Res       Date:  2011-06       Impact factor: 3.756

7.  Home oxygen therapy in infants with bronchopulmonary dysplasia: a prospective study.

Authors:  E Baraldi; S Carra; F Vencato; M Filippone; D Trevisanuto; O Milanesi; M Pinello; V Zanardo; F Zacchello
Journal:  Eur J Pediatr       Date:  1997-11       Impact factor: 3.183

8.  Hamsters vs. rats: metabolic and ventilatory response to development in chronic hypoxia.

Authors:  P B Frappell; J P Mortola
Journal:  J Appl Physiol (1985)       Date:  1994-12

9.  Growth and development in children recovering from bronchopulmonary dysplasia.

Authors:  T Markestad; P M Fitzhardinge
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

10.  New intrauterine growth curves based on United States data.

Authors:  Irene E Olsen; Sue A Groveman; M Louise Lawson; Reese H Clark; Babette S Zemel
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

View more
  2 in total

1.  Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity.

Authors:  Kathleen A Kennedy; Helen A Mintz-Hittner
Journal:  J AAPOS       Date:  2017-12-06       Impact factor: 1.220

2.  Growth Rates of Infants Randomized to Continuous Positive Airway Pressure or Intubation After Extremely Preterm Birth.

Authors:  Ariel A Salas; Waldemar A Carlo; Barbara T Do; Edward F Bell; Abhik Das; Krisa P Van Meurs; Brenda B Poindexter; Seetha Shankaran; Noelle Younge; Kristi L Watterberg; Rosemary D Higgins
Journal:  J Pediatr       Date:  2021-06-19       Impact factor: 6.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.